KZR stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Wells Fargo & Company MN, GSA Capital Partners LLP, Caas Capital Management LP, Opaleye Management Inc., Renaissance Technologies LLC, ProShare Advisors LLC, and State of Wisconsin Investment Board. Company insiders that have bought Kezar Life Sciences stock in the last two years include Christopher J Kirk, Equal Talent Investments Ltd, Franklin M Berger, John Franklin Fowler, Marc Belsky, Middleton Angus, Morningside Venture Investment, and Vassiliki Economides.
View insider buying and selling activity for Kezar Life Sciences or or view top insider-buying stocks.